BERNSTEIN HAROLD (President, R&D & CMO) sold 9.71K shares of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $254.5K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/8/2026ACC: 0002050172-26-000036
Officer· President, R&D & CMO
Since Mar 2026
-9.71K
Net shares
Net seller
$254.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.71K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.71K
Price / share
$26.22
Trade value
$254.50K
% of position
New position
9/4/2026
9.71K→0.00
Total
Net shares
−9.71K
Net value
-$254.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/4/2026 | S · Sale | −9.71K | $26.22 | $254.50K | New position | 9.71K | 0.00 |
| Total | −9.71K | -$254.50K | ||||||
Derivative Transactions0
No derivative transactions reported